Uncovering the pathology of a rare pediatric leukemia
from Northwestern Medicine
A team of scientists has demonstrated the mechanism by which ETO2-GLIS2, a gene fusion, promotes the development of an aggressive form of pediatric leukemia. The findings, published in Cancer Cell, also reveal an opportunity for the development of therapeutics.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063